Csenge Advisory Group Bio Rad Laboratories, Inc. Transaction History

Csenge Advisory Group

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$463.67 - $597.16 $25,038 - $32,246	-54 Reduced 11.23%	427 $211,000
Q1 2022 May 09, 2022	BUY	$524.57 - $735.42 $15,212 - $21,327	29 Added 6.42%	481 $271,000
Q4 2021 Feb 10, 2022	BUY	$708.84 - $794.68 $708 - $794	1 Added 0.22%	452 $297,000
Q3 2021 Oct 20, 2021	SELL	$657.71 - $825.77 $657 - $825	-1 Reduced 0.22%	451 $335,000
Q2 2021 Jul 21, 2021	SELL	$576.64 - $649.04 $2,883 - $3,245	-5 Reduced 1.09%	452 $297,000
Q1 2021 Apr 28, 2021	BUY	$547.01 - $662.35 $9,299 - $11,259	17 Added 3.86%	457 $275,000
Q4 2020 Jan 26, 2021	SELL	$510.68 - $643.45 $17,363 - $21,877	-34 Reduced 7.17%	440 $256,000
Q3 2020 Nov 09, 2020	BUY	$454.43 - $535.6 $14,087 - $16,603	31 Added 7.0%	474 $253,000
Q2 2020 Jul 17, 2020	BUY	$334.87 - $493.06 $148,347 - $218,425	443 New	443 $200,000
Q4 2018 Feb 07, 2019	SELL	$220.1 - $309.0 $6,603 - $9,270	-30 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$289.28 - $326.15 $8,678 - $9,784	30 New	30 $8,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.